Keywords: Systemic lupus erythematosus; Biologics; Belimumab; BLyS; BAFF;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Connective tissue diseases; systemic lupus erythematosus; rheumatoid arthritis; systemic sclerosis; vasculitis; biomarkers; AAV; ANCA-associated vasculitides; ACA; Anti-centromere antibody; ACPA; Anti-citrullinated protein antibody; ACR; American College
Keywords: Outcome measure; Biologics; Anti-CD20; BLyS; Registries; Lupus nephritis;
Effects of oridonin on immune cells, Th1/Th2 balance and the expression of BLys in the spleens of broiler chickens challenged with Salmonella pullorum
Keywords: Oridonin; Immune cell; Cytokines; BLys; Th1/Th2 balance; Broiler;
The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans
Keywords: CNS; central nervous system; LOTUS; lateral olfactory tract usher substance; s-LOTUS; the soluble form of LOTUS; NgR1; Nogo receptor type 1; MAIs; myelin-associated inhibitors; MAG; myelin-associated glycoprotein; OMgp; oligodendrocyte myelin glycoprotein
Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS
Keywords: BLyS; B lymphocyte stimulator; ChABC; chondroitinase ABC; CNS; central nervous system; CSPGs; chondroitin sulfate proteoglycans; DRG; dorsal root ganglion; GPI; glycosylphosphatidylinositol; HSV; herpes simplex virus; LAR; leukocyte common antigen-related
Generation and characterization of human B lymphocyte stimulator blocking monoclonal antibody
Keywords: Autoimmune; SLE; Blys; Antibody;
The comparison of BLyS-binding peptides from phage display library and computer-aided design on BLyS-TACI interaction
Keywords: BLyS; BLyS antagonists; Peptibody; Computer-aided design; Autoimmune diseases;
BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease
Keywords: ADA; Anti-drug antibody; BAFF; B-cell activating factor; ERT; Enzyme replacement therapy; FO; Follicular B-cell; GAA; Acid α-glucosidase; MZ; Marginal zone B-cell; rhGAA; Recombinant human GAA; TR; Transitional B-cell; Acid alpha-glucosidase; BAFF; BLyS;
Treatment with atacicept enhances neuronal cell death in a rat model of optic neuritis
Keywords: Optic neuritis; Atacicept; BLyS; APRIL; B cell; Experimental autoimmune encephalomyelitis;
Serum BLyS and APRIL as possible indicators of disease activity in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis
Keywords: Pediatric SLE; SLEDAI; JIA; JADAS-27; BLyS; APRIL
New roles for the BLyS/BAFF family in antigen-experienced B cell niches
Keywords: BLyS; BAFF; TACI; Germinal center
Mise au pointPhysiopathologie du lupus systémique : le point en 2014Etiopathogenesis of systemic lupus erythematosus: A 2014 update
Keywords: Lupus érythémateux systémique; Physiopathologie; Lymphocyte B; Interféron-α; BLys; Systemic lupus erythematosus; Etiopathogenesis; B-lymphocyte; α-interferon; BLys;
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
Keywords: B-lymphocyte activator factor (BAFF); Lymphoma; Primary Sjogren's syndrome (SS); Single nucleotide polymorphisms (SNPs); Genetics; BAFF; B-cell activating factor; BLyS; B lymphocyte stimulator; pSS; primary Sjogren's syndrome; SNPs; single nucleotide poly
BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII-dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells
Keywords: 2-APB; 2-aminoethoxydiphenyl borate; BAFF; B-cell activating factor of the TNF family; BAPTA/AM; 1,2-bis(o-aminophenoxy) ethane-N,N,Nâ²,Nâ²-tetraacetic acid tetra(acetoxymethyl) ester; BLyS; B lymphocyte stimulator; BCMA; B cell maturation antigen; CaM;
ReviewReprint of: B cell elimination in systemic lupus erythematosus
Keywords: ALMS; Aspreva Lupus Management Study; APRIL; proliferation inducing ligand; APS; antiphospholipid syndrome; BCDT; B cell depletion therapy; BILAG; British Isles Lupus Assessment Group; BLyS; B lymphocyte stimulator protein; ECLAM; European Community Lupus
The state of therapy for removal of alloantibody producing plasma cells in transplantation
Keywords: Proteasome; Bortezomib; Blys; Belimumab; Plasma cell; Alloantibodies; HLA; Transplantation
Primary B cell repertoire remodeling to achieve humoral transplantation tolerance
Keywords: B lymphocytes; Humoral tolerance; Transplantation; BLyS
The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma
Keywords: Mantle cell lymphoma; BLyS; BLyS receptor; Bortezomib; Combination
Bax345/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin
Keywords: Malignant B cells; BLyS; Bax; Mitochondria; Apoptosis
BLyS and APRIL expression in peripheral blood mononuclear cells of cryptococcal meningitis patients and their clinical significance
Keywords: Cryptococcal meningitis; BlyS; APRIL; TACI; BCMA; BAFF-R
BLyS and April serum levels in patients with autoimmune thyroid diseases
Keywords: BLyS; April; Autoimmune thyroid disease; Autoimmunity; Lymphoma
Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase
Keywords: BLyS; Fibroblast; Airway; dsRNA; PI3K
Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers
Keywords: Mechanism of action; Rheumatoid arthritis; Systemic lupus erythematosus; Sjögren's syndrome; Biomarker; B cell-targeting drugs; ACPA; anti-citrullinated peptide antibody; ACR; American College of Rheumatology; APRIL; a proliferation-inducing ligand; BCMA
Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
Keywords: APRIL; atacicept; BLyS; pharmacokinetics; systemic lupus erythematosus; bioavailability; dose-response/dose proportionality; nonlinear pharmacokinetics;
Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator
Keywords: Belimumab; Cynomolgus; Reproduction; Developmental study; Peri-postnatal study; Immunomodulation; BLyS; Nonhuman primates
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?
Keywords: Cryoglobulinemia; Hepatitis C virus; B cell; BLyS; Rituximab;
hsBAFF enhances activity of NK cells by regulation of CD4+ T lymphocyte function
Keywords: BAFF; B cell activating factor belonging to the TNF family; BLyS; B lymphocyte stimulator; BCMA; B cell maturation antigen; ELISA; enzyme linked immunosorbent assay; hsBAFF; human soluble BAFF; IFN-γ; interferon-gamma; IL-2; interleukin-2; NK; natural ki
Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium
Keywords: BLyS; B-lymphocyte stimulator; CI; confidence interval; DLBCL; diffuse large B-cell lymphoma; FL; follicular lymphoma; HCV; hepatitis C virus; InterLymph; International Lymphoma Epidemiology Consortium; LPL; lymphoplasmacytic lymphoma; MZL; marginal zone
BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells
Keywords: BLyS; APRIL; B lymphocyte; Homeostasis
Production and purification of recombinant human BLyS mutant from inclusion bodies
Keywords: BLyS; rBLyS mutant; Inclusion body; Purification;
Homeostatic niche specification among naïve and activated B cells: A growing role for the BLyS family of receptors and ligands
Keywords: B lymphocyte; Homeostasis; BLyS;
FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation
Keywords: BAFF; B cell-activating factor of the TNF family; BAFF-R; BAFF receptor; B-CLL; B cell chronic lymphocytic leukemia; BCR; B cell receptor; BL; Burkitt's lymphoma; BLyS; B lymphocyte stimulator; CB; centroblast; CC; centrocyte; D; domain; EBV; Epstein Barr
Optimization of BLyS production and purification from Escherichia coli
Keywords: B lymphocyte stimulator; BLyS; Escherichia coli; Fermentation; Purification; Periplasm;
1st International Conference on Cutaneous Lupus Erythematosus Düsseldorf, Germany, September 1-5, 2004
Keywords: ACLE; acute cutaneous lupus erythematosus; ACR; American College of Rheumatology; ADCC; antibody dependent cell-mediated cytotoxicity; aPL; antiphospholipid antibodies; APS; antiphospholipid syndrome; BlyS; B lymphocyte stimulator; CAMs; cellular adhesion
Biology of plasma cells
Keywords: plasma cell; multiple myeloma; cell cycle; p18IN4c; cyclin D; Cdk6; Cdk4; Rb; IL-6; TRAIL/APO2L; CD40; BlyS; BAFF;